EDSA: IND Expected in 2025 for EB06 for the Treatment of Vitiligo…
EDSA READ THE FULL EDSA RESEARCH REPORT Business Update Advancing EB06 for Treating Vitiligo Edesa Biotech, Inc. (NASDAQ:EDSA ...
Managed Healthcare Executive1 天
Combined Oral and Phototherapy Treatments Show Promise in Treating Severe Vitiligo
In a phase 2 clinical trial, researchers examined baricitinib and NB-UVB in adults with severe vitiligo in the dermatology ...